Functional Hemolytic Test for Complement Alternative Pathway Convertase Activity.

Michels, Marloes A H M; van de Kar, Nicole C A J; Volokhina, Elena B; van den Heuvel, Bert L P W J

Michels, Marloes A H M; van de Kar, Nicole C A J; Volokhina, Elena B; van den Heuvel, Bert L P W J.

Affiliation

Michels MAHM; Department of Pediatric Nephrology, Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
van de Kar NCAJ; Department of Pediatric Nephrology, Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
Volokhina EB; Department of Pediatric Nephrology, Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
van den Heuvel BLPWJ; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Methods Mol Biol ; 2227: 83-96, 2021.

Article de En | MEDLINE | ID: mdl-33847933

Sujet(s)
Mots clés

Alternative pathway; Atypical hemolytic uremic syndrome; C3 glomerulopathy; C3 nephritic factor; Complement; Convertase; Eculizumab; Hemolytic assay; Mutation; Rabbit erythrocytes

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dosage de l'activité hémolytique du complément / Voie alterne d'activation du complément / Complement C3-C5 Convertases Type d'étude: Diagnostic_studies Limites: Animals / Humans Langue: En Journal: Methods Mol Biol Sujet du journal: BIOLOGIA MOLECULAR Année: 2021 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google